NYSE:ABBV - AbbVie News Headlines

Sign in or create an account to add this stock to your watchlist.
$91.53 +1.39 (+1.54 %)
(As of 11/16/2018 04:00 PM ET)
Previous Close$90.14
Today's Range$89.20 - $92.00
52-Week Range$77.50 - $125.86
Volume8.62 million shs
Average Volume7.19 million shs
Market Capitalization$132.70 billion
P/E Ratio16.34
Dividend Yield4.35%
Beta1.62

Headlines

AbbVie (NYSE ABBV) News Headlines

Source:
DateHeadline
AbbVie Recognized as One of the Best Places to Work in Bosnia for 2018AbbVie Recognized as One of the Best Places to Work in Bosnia for 2018
www.marketwatch.com - November 16 at 3:14 PM
AbbVie Donates $55 Million to Three Education Nonprofits Supporting Underserved Youth in Chicago & Across AmericaAbbVie Donates $55 Million to Three Education Nonprofits Supporting Underserved Youth in Chicago & Across America
www.prnewswire.com - November 16 at 3:14 PM
11 NYSE- And NASDAQ-Listed Stocks With Cannabis Exposure11 NYSE- And NASDAQ-Listed Stocks With Cannabis Exposure
finance.yahoo.com - November 16 at 3:14 PM
DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline - November 20, 2018DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against AbbVie Inc. (ABBV) & Lead Plaintiff Deadline - November 20, 2018
finance.yahoo.com - November 16 at 3:14 PM
Gauging Analysts’ Views on Clovis StockGauging Analysts’ Views on Clovis Stock
finance.yahoo.com - November 16 at 3:14 PM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COCP, ABBV, CHGG, HON and DYThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of COCP, ABBV, CHGG, HON and DY
finance.yahoo.com - November 16 at 3:14 PM
ABBVIE LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 in AbbVie, Inc. to Contact the FirmABBVIE LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 in AbbVie, Inc. to Contact the Firm
finance.yahoo.com - November 16 at 5:10 AM
Mission Therapeutics and AbbVie Sign DUBs Collaboration in Alzheimer’s and Parkinson’s DiseaseMission Therapeutics and AbbVie Sign DUBs Collaboration in Alzheimer’s and Parkinson’s Disease
www.businesswire.com - November 15 at 3:10 PM
AbbVie teams up with Mission Therapeutics in Alzheimers and ParkinsonsAbbVie teams up with Mission Therapeutics in Alzheimer's and Parkinson's
seekingalpha.com - November 15 at 3:10 PM
Exploring Clovis Oncology’s Operational PerformanceExploring Clovis Oncology’s Operational Performance
finance.yahoo.com - November 15 at 3:10 PM
Understanding Clovis Oncology’s Gross Margin TrendUnderstanding Clovis Oncology’s Gross Margin Trend
finance.yahoo.com - November 15 at 3:10 PM
AbbVie Presents Positive Phase 3 Data Demonstrating Investigational Elagolix Reduces Heavy Menstrual Bleeding in ...AbbVie Presents Positive Phase 3 Data Demonstrating Investigational Elagolix Reduces Heavy Menstrual Bleeding in ...
www.prnewswire.com - November 15 at 5:14 AM
ABBV Is An Even Bigger Buy After The MidtermsABBV Is An Even Bigger Buy After The Midterms
seekingalpha.com - November 15 at 5:14 AM
AbbVie (ABBV) Receives Media Sentiment Rating of 0.90AbbVie (ABBV) Receives Media Sentiment Rating of 0.90
www.americanbankingnews.com - November 14 at 9:31 PM
AbbVie Presents Positive Phase 3 Data Demonstrating Investigational Elagolix Reduces Heavy Menstrual Bleeding in Women with Uterine Fibroids at 2018 AAGL Global CongressAbbVie Presents Positive Phase 3 Data Demonstrating Investigational Elagolix Reduces Heavy Menstrual Bleeding in Women with Uterine Fibroids at 2018 AAGL Global Congress
www.prnewswire.com - November 14 at 6:28 PM
AbbVies HCV Drug Mavyret Succeeds in Label Expansion StudyAbbVie's HCV Drug Mavyret Succeeds in Label Expansion Study
www.zacks.com - November 14 at 3:02 PM
AbbVies Mavyret delivers 100% cure rate in late-stage HCV studyAbbVie's Mavyret delivers 100% cure rate in late-stage HCV study
seekingalpha.com - November 13 at 3:19 PM
Global Crohns Disease Therapeutics Market to 2025 with Johnson & Johnson Services Inc. Pfizer Inc. Allergan and ...Global Crohn's Disease Therapeutics Market to 2025 with Johnson & Johnson Services Inc. Pfizer Inc. Allergan and ...
www.prnewswire.com - November 13 at 3:19 PM
AbbVies MAVYRET™ (glecaprevir/pibrentasvir) Shows High Virologic Cure* Rates in Treatment-Naïve Hepatitis C Patients with Compensated CirrhosisAbbVie's MAVYRET™ (glecaprevir/pibrentasvir) Shows High Virologic Cure* Rates in Treatment-Naïve Hepatitis C Patients with Compensated Cirrhosis
finance.yahoo.com - November 13 at 3:19 PM
SHAREHOLDER ALERT: APOG COCP ABBV COST HTHT SFIX CWH OZK NKTR SYF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action DeadlinesSHAREHOLDER ALERT: APOG COCP ABBV COST HTHT SFIX CWH OZK NKTR SYF: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines
feeds.benzinga.com - November 12 at 7:10 PM
The Medicines Patent Pool Signs Licence with AbbVie to Expand Access to Key Hepatitis C Treatment, Glecaprevir/PibrentasvirThe Medicines Patent Pool Signs Licence with AbbVie to Expand Access to Key Hepatitis C Treatment, Glecaprevir/Pibrentasvir
www.bizjournals.com - November 12 at 3:12 PM
INVESTOR REMINDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmINVESTOR REMINDER NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - November 12 at 3:12 PM
Why AbbVies Stock Cratered in OctoberWhy AbbVie's Stock Cratered in October
www.fool.com - November 12 at 8:14 AM
Why AbbVie's Stock Cratered in OctoberWhy AbbVie's Stock Cratered in October
finance.yahoo.com - November 12 at 8:13 AM
Short Interest in AbbVie Inc (ABBV) Drops By 22.1%Short Interest in AbbVie Inc (ABBV) Drops By 22.1%
www.americanbankingnews.com - November 12 at 2:16 AM
The Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OPK, ABBV, MGTI, HAS and CPBThe Klein Law Firm Reminds Investors of Class Actions on Behalf of Shareholders of OPK, ABBV, MGTI, HAS and CPB
finance.yahoo.com - November 11 at 3:10 PM
Hagens Berman Reminds AbbVie ABBV Investors of Ongoing Investigation of AbbVies Humira Sales PracticesHagens Berman Reminds AbbVie ABBV Investors of Ongoing Investigation of AbbVie's Humira Sales Practices
www.marketwatch.com - November 10 at 5:15 AM
Hagens Berman Reminds AbbVie (NYSE: ABBV) Investors of Ongoing Investigation of AbbVies Humira Sales PracticesHagens Berman Reminds AbbVie (NYSE: ABBV) Investors of Ongoing Investigation of AbbVie's Humira Sales Practices
finance.yahoo.com - November 10 at 5:15 AM
Neutral News Coverage Very Unlikely to Impact AbbVie (ABBV) Stock PriceNeutral News Coverage Very Unlikely to Impact AbbVie (ABBV) Stock Price
www.americanbankingnews.com - November 9 at 9:23 PM
AbbVie Characterizes Evolving Hepatitis C (HCV) Patient Landscape in the United States Using Comprehensive DatasetAbbVie Characterizes Evolving Hepatitis C (HCV) Patient Landscape in the United States Using Comprehensive Dataset
www.prnewswire.com - November 9 at 3:15 PM
AbbVie Foundation and Habitat for Humanity Lake County Build HousesAbbVie Foundation and Habitat for Humanity Lake County Build Houses
www.prnewswire.com - November 9 at 3:15 PM
CLASS ACTION UPDATE for ABBV, HON and DY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of ShareholdersCLASS ACTION UPDATE for ABBV, HON and DY: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
feeds.benzinga.com - November 9 at 1:52 PM
6 Pharmaceutical Stocks to Buy After the Midterms6 Pharmaceutical Stocks to Buy After the Midterms
investorplace.com - November 9 at 11:14 AM
AbbVie Inc (ABBV) to Post FY2018 Earnings of $7.95 Per Share, SunTrust Banks ForecastsAbbVie Inc (ABBV) to Post FY2018 Earnings of $7.95 Per Share, SunTrust Banks Forecasts
www.americanbankingnews.com - November 9 at 9:22 AM
AbbVie (ABBV) Gains As Market Dips: What You Should KnowAbbVie (ABBV) Gains As Market Dips: What You Should Know
finance.yahoo.com - November 9 at 6:01 AM
DEADLINE RAPIDLY APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the FirmDEADLINE RAPIDLY APPROACHING: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against AbbVie Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
finance.yahoo.com - November 9 at 6:01 AM
AbbVie Inc (ABBV) Expected to Announce Quarterly Sales of $8.36 BillionAbbVie Inc (ABBV) Expected to Announce Quarterly Sales of $8.36 Billion
www.americanbankingnews.com - November 9 at 3:04 AM
AbbVie Inc (ABBV) Given Consensus Recommendation of "Hold" by AnalystsAbbVie Inc (ABBV) Given Consensus Recommendation of "Hold" by Analysts
www.americanbankingnews.com - November 8 at 3:44 PM
AbbVie to set up new R&D hub in South San FranciscoAbbVie to set up new R&D hub in South San Francisco
seekingalpha.com - November 8 at 3:19 PM
AbbVie Delivers A Solid Beat And Raise QuarterAbbVie Delivers A Solid Beat And Raise Quarter
seekingalpha.com - November 8 at 3:19 PM
FY2019 EPS Estimates for AbbVie Inc Decreased by SunTrust Banks (ABBV)FY2019 EPS Estimates for AbbVie Inc Decreased by SunTrust Banks (ABBV)
www.americanbankingnews.com - November 8 at 9:37 AM
Equities Analysts Offer Predictions for AbbVie Incs FY2018 Earnings (ABBV)Equities Analysts Offer Predictions for AbbVie Inc's FY2018 Earnings (ABBV)
www.americanbankingnews.com - November 8 at 7:58 AM
Interim Report January - September 2018Interim Report January - September 2018
www.prnewswire.com - November 8 at 3:03 AM
The Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVieThe Daily Biotech Pulse: FDA Nod For Bristol-Myers Squibb, Momenta Strikes Patent License Deal With AbbVie
www.benzinga.com - November 7 at 3:16 PM
AbbVie sues Britains NHS over HCV eradication planAbbVie sues Britain's NHS over HCV eradication plan
seekingalpha.com - November 7 at 3:16 PM
How AbbVie Is Positioned in NovemberHow AbbVie Is Positioned in November
finance.yahoo.com - November 7 at 3:15 PM
A Look at AbbVie’s Operational PerformanceA Look at AbbVie’s Operational Performance
finance.yahoo.com - November 7 at 3:15 PM
What AbbVie’s Bottom Line Trend IndicatesWhat AbbVie’s Bottom Line Trend Indicates
finance.yahoo.com - November 7 at 3:15 PM
 Brokerages Anticipate AbbVie Inc (ABBV) Will Post Earnings of $1.92 Per Share Brokerages Anticipate AbbVie Inc (ABBV) Will Post Earnings of $1.92 Per Share
www.americanbankingnews.com - November 7 at 11:21 AM
William Blair Analysts Reduce Earnings Estimates for AbbVie Inc (ABBV)William Blair Analysts Reduce Earnings Estimates for AbbVie Inc (ABBV)
www.americanbankingnews.com - November 7 at 9:03 AM
This page was last updated on 11/16/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel